HUTCHMED (China) (HCM) Non-Current Deffered Revenue (2016 - 2025)
HUTCHMED (China) has reported Non-Current Deffered Revenue over the past 10 years, most recently at $20.1 million for Q4 2025.
- Quarterly Non-Current Deffered Revenue fell 58.43% to $20.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.1 million through Dec 2025, down 58.43% year-over-year, with the annual reading at $20.1 million for FY2025, 58.43% down from the prior year.
- Non-Current Deffered Revenue was $20.1 million for Q4 2025 at HUTCHMED (China), down from $48.4 million in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $69.5 million in Q4 2023 and troughed at $190000.0 in Q4 2022.
- The 4-year median for Non-Current Deffered Revenue is $34.3 million (2024), against an average of $34.6 million.
- Year-over-year, Non-Current Deffered Revenue soared 36468.42% in 2023 and then crashed 58.43% in 2025.
- A 4-year view of Non-Current Deffered Revenue shows it stood at $190000.0 in 2022, then soared by 36468.42% to $69.5 million in 2023, then crashed by 30.29% to $48.4 million in 2024, then crashed by 58.43% to $20.1 million in 2025.
- Per Business Quant, the three most recent readings for HCM's Non-Current Deffered Revenue are $20.1 million (Q4 2025), $48.4 million (Q4 2024), and $69.5 million (Q4 2023).